Drug Target - Beta-type platelet-derived growth factor receptor (PDGFRb)
|
|
US Patent Application: 20100081656
|
|
Patent Owner: IRM (USA)
|
|
 |
|
Drug Types
|
|
Small molecule drugs
|
|
 |
|
Target Diseases
Please refer to the patent or patent application for the complete list of target diseases
|
|
Acute pain,
Agitation,
Allergic contact dermatitis,
Allergic rhinitis,
Allergic sinusitis,
Alzheimer's disease,
Amyotrophic lateral sclerosis,
Anaphylactic syndrome,
Angioedema,
Anorexia,
Anxiety disorder,
Asthma,
Atopic dermatitis,
Autoimmune enteropathy,
Bacterial infection,
Bone loss,
Bone marrow fibrosis,
Bulimia,
Cancer,
Cancer pain,
Cardiac fibrosis,
Cerebral ischemia,
Chronic pain,
Cirrhosis in liver,
Conjunctivitis,
Crohn's disease,
Cutaneous lupus erythematosus,
Cutaneous necrotizing venulitis,
Cyclothymic disorder,
Cystic fibrosis,
Decreased libido,
Depression,
Dermatomyositis,
Diabetes,
Discoid lupus erythematosis,
Drug abuse,
Drug addiction,
Drug dependence,
Drug habituation,
Dysthymic disorder,
Erythema multiforme,
Erythema nodosum,
Fibrodysplasia ossificans progressiva,
Gouty arthritis,
Graft versus host disease,
Hair loss,
Hepatitis C infection,
HIV,
Huntington's chorea,
Indeterminate or infectious colitis,
Inflammation and tissue destruction,
Inflammatory muscle disorder,
Insect bite skin inflammation,
Interstitial cystitis,
Intestine inflammatory disease,
Liver fibrosis,
Local or systemic scleroderma,
Loss of concentration,
Macular degeneration,
Mastocytosis,
Mental slowing,
Motor Neuron Disease,
Multiple sclerosis,
Nasal polyposis,
Neuropathic pain,
Nociceptive pain,
Nodular panarteritis,
Nonalcoholic steatohepatitis,
Obesity,
Osteoarthritis,
Parkinson's disease,
Pessimistic worry,
Polyarthritis,
Polymyositis/dermatomyositis,
Post-menopause syndrome,
Postoperative pain,
Premenstrual syndrome,
Prion diseases,
Proliferative glomerulonephritis,
Psoriasis,
Psychogenic pain syndrome,
Pulmonary fibrosis,
Renal disease,
Rheumatoid arthritis,
Rheumatoid arthritis,
Rheumatoid spondylitis,
Schizophrenia,
Self-deprecation,
Sjogren's syndrome,
Systemic lupus erythematosus,
Tumor angiogenesis,
Ulcerative,
Urticaria,
Withdrawal syndrome
|
|
 |
|
Assays/Methods Used In This Patent Or Patent Application
Please refer to the patent or patent application for the complete list of methods used and the details of the protocols
|
- Upstate Kinase ProfilerTM--Radio-Enzymatic Filter Binding Assay
- Human TG-HA-VSMC Proliferation Assay
- Effect on Cell Cycle Distribution
- Proliferation Assay: BaF3 Library--Bright Glo Readout Protocol
- FLT3 and PDGFR beta (Cellular Assay)
|
|
|
|
Link to USPTO site
|
|
US Patent Application: 20100081656
|
|
|
|
|
Services offered
SciClips Consultancy
|
| Fostering innovation through scientific intelligence |
Sciclips consultancy service team is comprised of highly qualified and experienced scientists who have several years of research experience in
academic and industrial laboratories. We offer following custom services at competitive price:
Scientific and technical areas covered: Drug discovery, Stem cells, Genomics, Proteomics, Biomarkers, Clinical diagnostics,
Companion diagnostics, Molecular diagnostics, Personalized medicine (theranostics), Plant and agricultural biotechnology
Patent search: Custom intellectual property (IP) analysis; Comprehensive patent database search and evaluation |
Custom data analysis and data mining: From patents, research articles, meeting abstracts and web based information. Custom meta analysis. |
Competitive intelligence analysis: Comprehensive analysis of competitive technologies and products; Technology trend prediction; Identification of technology licensing opportunities; Acquisition target identification; Identification of collaborative technology development opportunities. |
Technology development: Identification of potential development opportunities in drug discovery assay development, cell based assay development, recombinant protein expression (in vitro and in vivo) and mass spectrometry/proteomics reagents and tools; Product development strategy. |
Diagnostics and Theranostics technology development: Diagnostic assay development; Diagnostic target identification (molecular or protein or miRNA or metabolomic biomarkers); Prognostic and drug efficacy biomarkers; Theranostics tools, biomarkers and therapeutic drug targets; Identification of emerging technologies and methods. |
Custom database development |
Customized bioinformatics tools: Offered through our partners. |
Proteomics and Drug discovery services (laboratory based): Offered through our partners. |
For more information on our consultancy services please contact us at contact@sciclips.com
or email us using the contact form
|
|
 |
|
|
Receive news updates by email
|
|
|
Search Drug Targets
|
|
|
Search Diseases
|
|
 |
|
|
Keywords:
High Content Screening, Cell Signaling Assays, Methyltransferase Assay, Drug Profiling Service, Pre-Clinical Services, Drug discovery assays, Cell based assays, HTS assays, clinical research services (CRO), GPCR cassays, receptor assays, kinase assays, phosphatase assays, toxicity assays, Reporter Assays,GPCR cell-based assays, Enzyme Inhibitors, screening molecules,Screening Assays,Screening compounds, Small Molecule Screening,Small Molecule Libraries, Raman Spectroscopy,kinase assays, protease assays, caspase assay,apoptosis assays, Receptor Assay, nuclear Receptor Assay,Receptor Binding Assay,Multiplex Assays, calcium assays, Ion Channel Screening, Sodium Channel Screening,HERG channel Assay,genotyping, ATP assay,Glutathione Assay, Genotoxicity assay,Flow Cytometry, Cell Proliferation Assay, Next generation sequencing, contract assay service, High Throughput Screening, Assay development, Drug Discovery Services, Cell based assays, Drug Profiling Service, Compound Profiling, Medicinal chemistry, ion channel assays
|
Drug Targets
